358 related articles for article (PubMed ID: 17532030)
21. Utility of mesothelin, L1CAM and Afamin as biomarkers in primary ovarian cancer.
Aktas B; Kasimir-Bauer S; Wimberger P; Kimmig R; Heubner M
Anticancer Res; 2013 Jan; 33(1):329-36. PubMed ID: 23267165
[TBL] [Abstract][Full Text] [Related]
22. Better Predictive Value of Cancer Antigen125 (CA125) as Biomarker in Ovary and Breast Tumors and its Correlation with the Histopathological Type/Grade of the Disease.
Nazmeen A; Maiti S; Mandal K; Roy SK; Ghosh TK; Sinha NK; Mandal K
Med Chem; 2017; 13(8):796-804. PubMed ID: 28440189
[TBL] [Abstract][Full Text] [Related]
23. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.
Anderson GL; McIntosh M; Wu L; Barnett M; Goodman G; Thorpe JD; Bergan L; Thornquist MD; Scholler N; Kim N; O'Briant K; Drescher C; Urban N
J Natl Cancer Inst; 2010 Jan; 102(1):26-38. PubMed ID: 20042715
[TBL] [Abstract][Full Text] [Related]
24. Combination of serum hCG beta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma.
Vartiainen J; Lassus H; Lehtovirta P; Finne P; Alfthan H; Butzow R; Stenman UH
Int J Cancer; 2008 May; 122(9):2125-9. PubMed ID: 18098286
[TBL] [Abstract][Full Text] [Related]
25. Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma.
McIntosh MW; Drescher C; Karlan B; Scholler N; Urban N; Hellstrom KE; Hellstrom I
Gynecol Oncol; 2004 Oct; 95(1):9-15. PubMed ID: 15385104
[TBL] [Abstract][Full Text] [Related]
26. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
Spencer K; Aitken DA; Macri JN; Buchanan PD
Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
[TBL] [Abstract][Full Text] [Related]
27. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
[TBL] [Abstract][Full Text] [Related]
28. Urinary levels of Bcl-2 are elevated in ovarian cancer patients.
Anderson NS; Bermudez Y; Badgwell D; Chen R; Nicosia SV; Bast RC; Kruk PA
Gynecol Oncol; 2009 Jan; 112(1):60-7. PubMed ID: 19007973
[TBL] [Abstract][Full Text] [Related]
29. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.
Hassan R; Remaley AT; Sampson ML; Zhang J; Cox DD; Pingpank J; Alexander R; Willingham M; Pastan I; Onda M
Clin Cancer Res; 2006 Jan; 12(2):447-53. PubMed ID: 16428485
[TBL] [Abstract][Full Text] [Related]
30. Cross-reaction with luteinizing hormone beta-core is responsible for the age-dependent increase of immunoreactive beta-core fragment of human chorionic gonadotropin in women with nonmalignant conditions.
Iles RK; Javid MK; Gunn LK; Chard T
Clin Chem; 1999 Apr; 45(4):532-8. PubMed ID: 10102914
[TBL] [Abstract][Full Text] [Related]
31. Elevation of multiple serum markers in patients with stage I ovarian cancer.
Woolas RP; Xu FJ; Jacobs IJ; Yu YH; Daly L; Berchuck A; Soper JT; Clarke-Pearson DL; Oram DH; Bast RC
J Natl Cancer Inst; 1993 Nov; 85(21):1748-51. PubMed ID: 8411259
[TBL] [Abstract][Full Text] [Related]
32. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.
Creaney J; van Bruggen I; Hof M; Segal A; Musk AW; de Klerk N; Horick N; Skates SJ; Robinson BW
Chest; 2007 Oct; 132(4):1239-46. PubMed ID: 17646232
[TBL] [Abstract][Full Text] [Related]
33. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
[TBL] [Abstract][Full Text] [Related]
34. Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.
Lowe KA; Shah C; Wallace E; Anderson G; Paley P; McIntosh M; Andersen MR; Scholler N; Bergan L; Thorpe J; Urban N; Drescher CW
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2480-7. PubMed ID: 18768519
[TBL] [Abstract][Full Text] [Related]
35. Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption.
Hollevoet K; Speeckaert MM; Decavele AS; Vanholder R; van Meerbeeck JP; Delanghe JR
Clin Lung Cancer; 2012 Nov; 13(6):470-4. PubMed ID: 22386954
[TBL] [Abstract][Full Text] [Related]
36. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
Plebani M; Navaglia F; Basso D; De Paoli M; Nicoletto MO; Maraglino E; Torre GC
Anticancer Res; 1996; 16(6B):3833-8. PubMed ID: 9042266
[TBL] [Abstract][Full Text] [Related]
37. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
Hotakainen K; Haglund C; Paju A; Nordling S; Alfthan H; Rintala E; Stenman UH
Eur Urol; 2002 Jun; 41(6):677-85. PubMed ID: 12074787
[TBL] [Abstract][Full Text] [Related]
38. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
[TBL] [Abstract][Full Text] [Related]
39. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
40. Elevated serum nicked and urinary beta-core fragment hCG in preeclamptic pregnancies.
Lee IS; Chung DY; Cole LA; Copel JA; Isozaki T; Hsu CD
Obstet Gynecol; 1997 Dec; 90(6):889-92. PubMed ID: 9397096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
